Health Catalyst (NASDAQ:HCAT) Issues Earnings Results, Misses Estimates By $0.02 EPS

Health Catalyst (NASDAQ:HCAT) posted its earnings results on Thursday. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.02), FiscalAI reports. Health Catalyst had a negative return on equity of 6.67% and a negative net margin of 34.05%.The business had revenue of $74.68 million for the quarter, compared to analyst estimates of $73.99 million.

Health Catalyst Trading Down 3.8%

NASDAQ:HCAT traded down $0.07 on Thursday, reaching $1.79. 468,695 shares of the stock traded hands, compared to its average volume of 807,745. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.46. Health Catalyst has a 1-year low of $1.56 and a 1-year high of $5.06. The company’s 50 day moving average is $2.08 and its 200-day moving average is $2.59. The firm has a market capitalization of $126.61 million, a price-to-earnings ratio of -1.13 and a beta of 1.76.

Analysts Set New Price Targets

HCAT has been the subject of several analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Health Catalyst in a research note on Monday, December 29th. Citigroup reduced their price objective on shares of Health Catalyst from $3.25 to $2.75 and set a “neutral” rating on the stock in a research note on Friday, January 9th. Five equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $4.06.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in HCAT. nVerses Capital LLC acquired a new position in shares of Health Catalyst in the 4th quarter valued at about $25,000. Cresset Asset Management LLC acquired a new stake in Health Catalyst during the second quarter worth approximately $39,000. Focus Partners Wealth bought a new stake in Health Catalyst in the first quarter worth approximately $46,000. BNP Paribas Financial Markets lifted its stake in Health Catalyst by 71.7% in the third quarter. BNP Paribas Financial Markets now owns 16,355 shares of the company’s stock valued at $47,000 after buying an additional 6,832 shares during the period. Finally, Quadrature Capital Ltd acquired a new position in Health Catalyst in the fourth quarter valued at approximately $64,000. 85.00% of the stock is owned by institutional investors.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.